Published in BMC Cancer on June 17, 2010
Role of genetic & environment risk factors in the aetiology of colorectal cancer in Malaysia. Indian J Med Res (2014) 1.27
Refining the role for adult stem cells as cancer cells of origin. Trends Cell Biol (2014) 0.88
Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population. Hum Genomics (2011) 0.84
Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum Genomics (2011) 0.84
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas. BMC Cancer (2014) 0.83
The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley. Mol Med Rep (2012) 0.77
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13
Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer (2007) 10.27
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol (2002) 5.07
DPC4 gene in various tumor types. Cancer Res (1996) 3.74
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta (2006) 3.64
Role of transforming growth factor Beta in human cancer. J Clin Oncol (2005) 3.53
TGF-beta and cancer. Cytokine Growth Factor Rev (2005) 3.38
Smads as transcriptional co-modulators. Curr Opin Cell Biol (2000) 2.92
The genetics of colorectal cancer. Ann Intern Med (2002) 2.62
Mad-related genes in the human. Nat Genet (1996) 2.51
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell (2007) 2.36
Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene (2005) 2.24
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene (1999) 2.22
Epidemiology of colorectal cancer. Br Med Bull (2002) 1.87
Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci (2009) 1.87
Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem (2008) 1.83
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut (2005) 1.73
Frequency of Smad gene mutations in human cancers. Cancer Res (1997) 1.73
Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology (2009) 1.49
Agricultural exposures and cancer. Environ Health Perspect (1995) 1.49
Smad4-mediated TGF-beta signaling in tumorigenesis. Int J Biol Sci (2010) 1.47
Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clin Cancer Res (2004) 1.41
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol (1998) 1.41
Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res (1988) 1.40
An update on the genetics of colorectal cancer. Hum Mol Genet (2004) 1.39
p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer (2005) 1.28
Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis (1992) 1.21
Structural insights on Smad function in TGFbeta signaling. Bioessays (2001) 1.19
Pattern of cancer at Srinagar (Kashmir). Indian J Pathol Microbiol (1990) 1.18
A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol (2006) 1.13
Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene (1999) 1.13
Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol (1993) 1.12
Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res (1999) 1.07
Pesticide use and colorectal cancer risk in the Agricultural Health Study. Int J Cancer (2007) 1.06
Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem (2009) 1.04
APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg (2005) 1.03
The Smads. Genome Biol (2001) 1.03
Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Indian J Cancer (2009) 0.99
Questionnaire assessment of nonoccupational pesticide exposure in epidemiologic studies of cancer. J Expo Anal Environ Epidemiol (2002) 0.96
Pesticides as a cause of occupational skin diseases in farmers. Ann Agric Environ Med (2001) 0.96
Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol (2001) 0.92
Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan. Exp Oncol (2004) 0.90
Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol (2009) 0.88
High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients. Int J Cancer (2003) 0.81
Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res (2009) 0.78
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev (2010) 1.03
Squamous cell carcinoma of rectum presenting in a man: a case report. J Med Case Rep (2010) 0.97
Effect of highly active anti-retroviral therapy on CD3+/CD4+/CD8+ T lymphocyte counts in HIV seropositive Kashmiri patients: a follow up study. Indian J Pathol Microbiol (2007) 0.92
Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog (2011) 0.90
Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr (2006) 0.89
Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer. Urol Oncol (2010) 0.88
Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol (2009) 0.88
Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection. BMC Cancer (2009) 0.86
Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study. Mol Med Rep (2013) 0.86
Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study. Oncol Lett (2013) 0.85
Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population. Hum Genomics (2011) 0.84
Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum Genomics (2011) 0.84
XRCC3 Thr241Met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study. Asian Pac J Cancer Prev (2014) 0.84
Improved diagnosis of central nervous system tuberculosis by MPB64-Target PCR. Braz J Microbiol (2008) 0.84
HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population. Urol Oncol (2011) 0.84
Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario. Tumour Biol (2012) 0.83
Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India). Tumour Biol (2012) 0.82
Evaluation of polymerase chain reaction for rapid diagnosis of clinically suspected tuberculous pleurisy. Indian J Clin Biochem (2006) 0.82
5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir. Asian Pac J Cancer Prev (2012) 0.82
DNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population. DNA Cell Biol (2011) 0.81
Mutations in epidermal growth factor receptor gene in esophageal squamous cell carcinoma patients in kashmir- a high incidence area of India. Int J Health Sci (Qassim) (2008) 0.81
Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. J Recept Signal Transduct Res (2011) 0.81
Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir. Mutat Res (2010) 0.79
Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumour Biol (2012) 0.79
Polymorphic analysis of MHClinked Heat Shock Protein 70 genes: Their susceptibility and prognostic implication in Kangri cancer cases of Kashmiri population. Indian J Hum Genet (2009) 0.79
Role of skin prick test in allergic disorders: a prospective study in kashmiri population in light of review. Indian J Dermatol (2013) 0.79
Promoter methylation profile of GSTP1 and RASSF1A in benign hyperplasia and metastatic prostate cancer patients in a Kashmiri population. Mol Med Rep (2010) 0.79
Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Biochem Genet (2011) 0.79
BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area. Cancer Lett (2006) 0.78
CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population. Asian Pac J Cancer Prev (2009) 0.78
Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res (2009) 0.78
The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley. Mol Med Rep (2012) 0.77
Pattern of adrenal morphology and function in pulmonary tuberculosis: response to treatment with antitubercular therapy. Clin Endocrinol (Oxf) (2013) 0.77
TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population. Asian Pac J Cancer Prev (2011) 0.76
GSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population. DNA Cell Biol (2011) 0.76
Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population. Asian Pac J Cancer Prev (2010) 0.76
SMAD4 promoter hypermethylation in Kashmiri colorectal cancer cases. Saudi J Gastroenterol (2011) 0.76
RAD51 G135C gene polymorphism and risk of colorectal cancer in Kashmir. Eur J Cancer Prev (2014) 0.76
Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population. Urol J (2010) 0.76
A case of primary amenorrhea with 46+XY genotype from Kashmir Valley. Indian J Hum Genet (2013) 0.75
Adenocarcinoma of the colon and rectum in the Kashmiri population. Indian J Hum Genet (2009) 0.75
A Rare Case of FAP in Kashmir Valley. Indian J Surg (2011) 0.75
Screening of N-ras gene mutations in urothelial cell carcinomas of the urinary bladder in the Kashmiri population. Asian Pac J Cancer Prev (2009) 0.75
Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study. Eur J Cancer Prev (2017) 0.75
Mutational profile of the CAV-1 gene in breast cancer cases in the ethnic Kashmiri population. Asian Pac J Cancer Prev (2010) 0.75
Polymorphism of the DNA Repair Gene XRCC1 (Arg194Trp) and its role in Colorectal Cancer in Kashmiri Population: a Case Control Study. Asian Pac J Cancer Prev (2015) 0.75
IL-1β polymorphism and expression associated with decreased risk of gastric carcinoma: a case control study in the ethnic Kashmiri population, India. Asian Pac J Cancer Prev (2015) 0.75
Oncogenic Activation of Fibroblast Growth Factor Receptor-3 and RAS Genes as Non-Overlapping Mutual Exclusive Events in Urinary Bladder Cancer. Asian Pac J Cancer Prev (2016) 0.75
SNP and Haplotype Analysis of Vascular Endothelial Growth Factor (VEGF) Gene in Lung Cancer Patients of Kashmir Asian Pac J Cancer Prev (2017) 0.75
PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide. Asian Pac J Cancer Prev (2016) 0.75